Core Viewpoint - Procter & Gamble is considered a viable option for long-term accumulation for the first time since October 2022, trading around $150, which is the same level seen four years ago [1]. Financial Performance - The company is noted for its operating and free cash flow, indicating strong financial health [1]. Investment Strategy - The analysis emphasizes a value-oriented approach, suggesting that valuation is more indicative of long-term opportunities or risks rather than short- to mid-term timing [1].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Perrigo Company plc securities between February 27, 2023, and November 4, 2025, due to alleged misleading statements and undisclosed issues related to the company's infant formula business [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from significant underinvestment and required substantial capital expenditures [5]. - Allegations include significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [5]. - The lawsuit asserts that when the true details became known, investors suffered damages due to the misleading nature of Perrigo's positive statements about its business and operations [5]. Group 2: Class Action Participation - Investors who purchased Perrigo securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the court by January 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing investor rights [4].

Core Insights - Nebius Group N.V. is experiencing financial losses and is considered "too speculative" by Jim Cramer, who recommends Dell Technologies as a more stable investment option [1] - Nebius reported third-quarter revenue of $146.1 million, which fell short of analyst expectations of $155.11 million [1] - The company posted an adjusted loss of 40 cents per share, which was better than the anticipated loss of 49 cents per share [2] - Nebius has initiated an at-the-market equity program for up to 25 million shares [2] Price Action - Nebius shares increased by 5% to close at $95.07 [5] - Dell shares decreased by 2.7% to close at $119.38 [5] - Kenvue shares fell by 1.1% to settle at $16.06 [5] Analyst Ratings - Barclays analyst Lauren Lieberman maintained an Equal-Weight rating on Kenvue and raised the price target from $17 to $18 [3]

Core Viewpoint - Warren Buffett will step down as CEO of Berkshire Hathaway at the end of the year, with Greg Abel set to take over, raising questions about the company's future performance and stock value post-Buffett [1][2]. Group 1: Succession Planning - Succession planning has been a focus for years due to Buffett's age, with concerns about whether the next CEO can maintain the company's market-beating performance [3]. - Greg Abel has been confirmed as the successor, with a clear timeline for the transition, and is expected to uphold the company's culture and values [4]. Group 2: Market Position and Comparisons - Unlike tech companies that heavily rely on visionary CEOs, Berkshire Hathaway's steady and calculated approach may mitigate risks associated with the CEO change [5][6]. - The example of Apple post-Steve Jobs illustrates that a company can continue to thrive under new leadership, as Tim Cook has led Apple to a market cap of $4 trillion [6]. Group 3: Investment Perspective - Investors should focus on the business rather than just the individual CEO, as strong management teams and established policies can ensure continued success [7]. - Berkshire Hathaway's current trading at 16 times its trailing earnings is considered attractive compared to the S&P 500 average of around 26, suggesting it may be an undervalued long-term buy [10]. - There is potential for improvement in Berkshire's portfolio, which includes slow-growing companies, indicating that leadership changes could lead to better returns [9].

Group 1 - Stock futures are climbing following Nvidia's earnings report, indicating positive market sentiment [1] - Defensive stocks, particularly in consumer staples, are experiencing declines, with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.4% [1] - Major holdings in the XLP include Colgate-Palmolive, PepsiCo, Walmart, and Costco, which are facing downward pressure [1] Group 2 - State Street's S&P Dividend ETF is also seeing a decline, reflecting challenges in dividend-paying stocks [2]

ATLANTA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Perrigo Company plc (“Perrigo”) (NYSE: PRGO). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose key facts, including allegations that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) Perrigo needed to make substantial capital and operational ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Perrigo Company plc, alleging misrepresentations related to its infant formula business acquired from Nestlé, affecting investors who purchased securities between February 27, 2023, and November 4, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Perrigo securities during the specified period [1]. - Defendants are accused of making false statements regarding the infant formula business [2]. - Investors interested in participating as lead plaintiffs must file by January 16, 2026 [3]. Group 2: Legal Representation - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented large public and private pension funds [4]. - The firm operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless there is a recovery [3].

Core Insights - Class actions have been initiated on behalf of stockholders of Skye Bioscience, Inc. and Perrigo Company plc, with deadlines for lead plaintiff petitions set for January 16, 2026 [1][3][7]. Perrigo Company plc - The class period for Perrigo is from February 27, 2023 to November 4, 2025, during which the company allegedly failed to disclose significant issues in its infant formula business acquired from Nestlé, including underinvestment and manufacturing deficiencies [3][4]. - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a reduction in its fiscal year 2025 outlook primarily due to challenges in the infant formula industry [4]. - Following the announcement, Perrigo's stock price dropped by $5.09, or 25.2%, closing at $15.10 per share [4]. Skye Bioscience, Inc. - The class period for Skye is from November 4, 2024 to October 3, 2025, during which the company allegedly made materially false statements regarding the effectiveness and prospects of its drug nimacimab [7]. - On October 6, 2025, Skye disclosed that the nimacimab monotherapy did not achieve its primary endpoint in a clinical study, resulting in a stock price decline of $2.85, or 60%, closing at $1.90 per share [7].

Core Points - A shareholder class action lawsuit has been filed against Perrigo Company plc, alleging that the company made materially false and misleading statements regarding its infant formula business acquired from Nestlé [1] - The lawsuit claims significant underinvestment in maintenance and operational improvements in the infant formula business, necessitating substantial capital and operational expenditures beyond stated cost estimates [1] - Allegations include significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [1] - The lawsuit asserts that positive statements made by the defendants about the company's business and prospects were materially misleading and lacked a reasonable basis [1] Legal Context - Shareholders who purchased Perrigo shares between February 27, 2023, and November 4, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request appointment as lead plaintiff in the case is January 16, 2026 [3] - Holzer & Holzer, LLC is representing shareholders in this litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]

Economic Overview - The S&P 500 has declined by 1.5% in November, a month typically strong for the U.S. stock market, due to negative economic news and concerns over high valuations, particularly in artificial intelligence stocks [2][7] - The U.S. manufacturing sector has contracted for eight consecutive months, as indicated by the ISM Manufacturing Purchasing Managers' Index (PMI), which reflects declines across all five categories [4][5][7] Impact of Tariffs - Tariffs are significantly impacting U.S. companies and consumers, contrary to the belief that foreign exporters would bear the costs. This has led to rising Consumer Price Index (CPI) inflation since April [6] - Apple reported $1.1 billion in tariff-related cost increases for the September quarter, with expectations of rising to $1.4 billion in the December quarter [8] - Caterpillar anticipates an incremental tariff impact of $1.6 billion to $1.75 billion for 2025 [8] - Chipotle is experiencing mid-single-digit inflation due to tariffs, particularly affecting beef prices, leading to reduced consumer dining out [8] - Ford expects tariffs to create a $1 billion headwind in 2025, with similar impacts anticipated in 2026 [8] - Procter & Gamble raised prices on 25% of its products to offset approximately $1 billion in tariff-related costs [8] - Target reported a 20% decrease in second-quarter earnings, primarily attributed to tariff-related cost increases [8] - Walmart continues to see rising costs as it replenishes inventory at post-tariff price levels [8]